Tharimmune, Inc. — Director's Dealing 2023

Nov 9, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tharimmune, Inc. (THAR)
CIK: 0001861657
Period of Report: 2022-11-07

Reporting Person: Appajosyula Sireesh (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-11-07	Options (right to buy)	$0.1577	A	25000	Acquired	2033-11-07	Common stock (25000)	Direct

Footnotes

F1: On November 7, 2023, the Reporting Person was granted options ("Options") to purchase up to 25,000 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant.